rc 3095 has been researched along with rolipram in 1 studies
Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (rolipram) | Trials (rolipram) | Recent Studies (post-2010) (rolipram) |
---|---|---|---|---|---|
108 | 2 | 26 | 1,604 | 17 | 401 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abujamra, AL; Brunetto, AL; de Farias, CB; Kapczinski, F; Roesler, R; Schmidt, AL; Schwartsmann, G | 1 |
1 other study(ies) available for rc 3095 and rolipram
Article | Year |
---|---|
BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Bombesin; Brain-Derived Neurotrophic Factor; Cell Survival; Child; Cyclic Nucleotide Phosphodiesterases, Type 4; Gastrin-Releasing Peptide; Gastrointestinal Agents; Humans; Medulloblastoma; Neurotransmitter Agents; Peptide Fragments; Phosphodiesterase Inhibitors; Receptor, trkB; Receptors, Bombesin; Recombinant Proteins; Rolipram | 2010 |